We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDW icon
2226
Tidewater
TDW
$3.91B
$766 ﹤0.01%
+14
New +$797
MED icon
2227
Medifast
MED
$140M
$759 ﹤0.01%
43
-1,575
-97% -$29.2K
CIM
2228
Chimera Investment
CIM
$985M
$756 ﹤0.01%
+54
New +$810
ZEUS
2229
DELISTED
Olympic Steel
ZEUS
$755 ﹤0.01%
+23
New +$892
NTGR icon
2230
NETGEAR
NTGR
$651M
$753 ﹤0.01%
+27
New +$635
SIGI icon
2231
Selective Insurance
SIGI
$5.76B
$749 ﹤0.01%
8
-3
-27% -$287
PRA
2232
DELISTED
ProAssurance
PRA
$748 ﹤0.01%
47
AROW icon
2233
Arrow Financial
AROW
$673M
$747 ﹤0.01%
26
-38
-59% -$1.16K
VHC icon
2234
VirnetX Holding Corp
VHC
$59.4M
$746 ﹤0.01%
95
BEAM icon
2235
Beam Therapeutics
BEAM
$2.77B
$744 ﹤0.01%
+30
New +$766
PRLB icon
2236
Protolabs
PRLB
$2.14B
$743 ﹤0.01%
19
-60
-76% -$2.16K
DCGO icon
2237
DocGo
DCGO
$62.4M
$742 ﹤0.01%
+175
New +$674
SAFT icon
2238
Safety Insurance
SAFT
$1.52B
$742 ﹤0.01%
9
-47
-84% -$3.89K
APPF icon
2239
AppFolio
APPF
$6.86B
$741 ﹤0.01%
3
-1
-25% -$234
OMER icon
2240
Omeros
OMER
$929M
$741 ﹤0.01%
75
-105
-58% -$721
ONC
2241
BeOne Medicines Ltd
ONC
$34.2B
$739 ﹤0.01%
4
SOBO
2242
South Bow Corp
SOBO
$7.42B
$731 ﹤0.01%
+31
New +$759
ZVRA icon
2243
Zevra Therapeutics
ZVRA
$621M
$726 ﹤0.01%
87
RELY icon
2244
Remitly
RELY
$5.14B
$723 ﹤0.01%
+32
New +$589
LUNG icon
2245
Pulmonx
LUNG
$84.1M
$720 ﹤0.01%
106
+13
+14% +$86
NARI
2246
DELISTED
Inari Medical, Inc. Common Stock
NARI
$715 ﹤0.01%
+14
New +$688
RUN icon
2247
Sunrun
RUN
$2.51B
$713 ﹤0.01%
+77
New +$956
HAE icon
2248
Haemonetics
HAE
$3.84B
$703 ﹤0.01%
9
-30
-77% -$2.41K
HST icon
2249
Host Hotels & Resorts
HST
$17.3B
$701 ﹤0.01%
40
-69
-63% -$1.24K
EYE icon
2250
National Vision
EYE
$1.86B
$699 ﹤0.01%
+67
New +$733

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.